Vanantwerp

Vanantwerp v. GlaxoSmithKline, LLC

Good Law
United States District Court, Northern District of CaliforniaOctober 17, 20243:24-cv-06964California377 words

Opinion

Trial Court Opinion

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: ZANTAC (RANITIDINE) PRODUCTS

LIABILITY LITIGATION MDL No. 2924

cmomenre nine file (SEE ATTACHED SCHEDULE) ew eee dt Adams SS Oct 17, 2024" CONDITIONAL TRANSFER ORDER (CTO —128)

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 437 F.Supp.3d 1368 (J.P.M.L. 2020). Since that time, 444 additional action(s) have been transferred to the Southern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable Robin L. Rosenberg. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Florida and assigned to Judge Rosenberg. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Southern…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.